Less Ads, More Data, More Tools Register for FREE

Pin to quick picksFD Technologies Regulatory News (FDP)

  • This share is currently suspended. It was suspended at a price of 2,450.00
  • There is currently no data for FDP

Directorate Change

10 Dec 2012 07:00

RNS Number : 0918T
First Derivatives PLC
10 December 2012
 



First Derivatives plc

("First Derivatives" or the "Company")

 

Directorate Change

 

First Derivatives plc (AIM: FDP.L, ESM: GYQ.I), a leading provider of software and consulting services to the capital markets industry, is pleased to announce the appointment of Seamus Keating as a Non Executive Director of the Company.

 

Seamus has over twenty years experience in the global technology sector in both finance and operational roles and was a main board director of Logica plc from 2002 until April 2012. He was Logica Group CFO until 2010 when he became COO and head of its Benelux operations. He also chaired the group's worldwide Financial Services practice. Having implemented a major restructuring plan in the Benelux region, he resigned from Logica plc, ahead of its acquisition by CGI of Canada. Prior to his role at Logica, he worked for the Olivetti Group in finance roles in the UK and Italy. He is currently working in the mid market private equity technology sector.

 

Seamus joined the board of Mouchel Group plc and became chair of the audit committee in November 2010, following a number of profit warnings, and remained on the board until September 2012, when the company was restructured and placed into Administration and its business purchased by a buyout company owned by its lenders.

 

Brian Conlon, CEO of First Derivatives, commented; "I am delighted to welcome a Director of Seamus' pedigree to the Board. His wide ranging experience with world class technology businesses in our sector will provide valuable insights as we expand the size and the breadth of our business."

 

Details of directorships that Seamus Declan Keating, aged 49, holds, or has held in the previous five years, are given below:

 

Current directorships:

Skapital Limited

 

Past directorships:

Logica PLC

Mouchel Group plc

 

Save for the declarations above there is no further information to be disclosed under Rule 17 or Schedule Two paragraph (g) of the AIM Rules for Companies.

 

 

Enquiries:

 

First Derivatives plc

+44(0)28 3025 2242

Brian Conlon, Chief Executive

www.firstderivatives.com

Graham Ferguson, Chief Financial Officer

Charles Stanley SecuritiesNominated Adviser and Broker

+44 (0)20 7149 6000

Russell Cook

Carl Holmes

Goodbody Corporate FinanceESM Adviser and Broker

+353 1 667 0420

Diane Hodgson

Linda Hickey

Walbrook PR

+44 (0)20 7933 8780

Bob Huxford

bob.huxford@walbrookpr.com

Paul Cornelius

paul.cornelius@walbrookir.com

Stakeholder Communications

+44 (0) 2890 339949

Jonathan King

John Hart

 

 

About First Derivatives

 

First Derivatives is a global provider of software and consulting services to the financial services industry. With over 15 years experience working with leading financial institutions, it continues to deliver technologically advanced, award winning products and services that anticipate and respond to the evolving needs of global capital markets.

 

First Derivatives currently employs over 710 people worldwide and counts many of the world's top investment banks, brokers and hedge funds as its customers. It has operations in London, New York, Stockholm, Shanghai, Singapore, Toronto, Sydney, Dublin, Newry and Hong Kong.

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
BOALKLLBLLFEFBX
Date   Source Headline
6th Nov 20127:00 amRNSHalf Yearly Report
2nd Nov 20129:57 amRNSTotal Voting Rights
18th Oct 20127:00 amRNSAppointment of Global Head of Software Sales
12th Oct 20127:00 amRNSNotice of results
28th Sep 20127:00 amRNSAcquisitions
7th Sep 20127:00 amRNSEnterprise Securities Market Notice
3rd Sep 20121:49 pmRNSIssue of Equity
17th Aug 20125:29 pmRNSDirector/PDMR Shareholding
31st Jul 20128:00 amRNSTotal Voting Rights
10th Jul 20127:00 amRNSEnterprise Securities Market Notice
5th Jul 20127:00 amRNSIssue of Equity
28th Jun 20123:08 pmRNSResult of AGM
28th Jun 20127:00 amRNSAGM Statement
12th Jun 20127:00 amRNSStrategic Partnership signed with FOREX CLUB
30th May 201211:59 amRNSDirectorate Change
28th May 20127:00 amRNSFinal Results
21st May 20127:00 amRNSCollaboration for "Bandwidth Exchange"
9th May 20127:00 amRNSNotice of Results
10th Apr 20127:00 amRNSContract win with major Australian bank
30th Mar 201211:56 amRNSTotal Voting Rights
15th Mar 20127:00 amRNSEnterprise Securities Market Notice
9th Mar 20124:16 pmRNSIssue of Equity
9th Feb 20121:30 pmRNSThomson Reuters Goes Live with Delta Data Factory
23rd Dec 20117:00 amRNSDirectors' Grant of Options
8th Dec 20118:00 amRNSDirector/PDMR Shareholding
2nd Dec 201110:15 amRNSTotal Voting Rights
18th Nov 20117:00 amRNSEnterprise Securities Market Notice
15th Nov 20117:00 amRNSIssue of Equity
18th Oct 20117:00 amRNSHalf Yearly Report
6th Oct 20117:00 amRNSNotice of Results
1st Aug 20111:29 pmRNSTotal Voting Rights
28th Jul 20114:26 pmRNSHolding(s) in Company
28th Jul 20114:25 pmRNSHolding(s) in Company
7th Jul 20112:16 pmRNSDirector Shareholding
4th Jul 201111:18 amRNSIssue of Equity
30th Jun 201112:38 pmRNSResult of AGM
30th Jun 201111:00 amRNSAGM Statement
25th May 20117:00 amRNSFinal Results
10th May 20117:00 amRNSNotice of Results
28th Apr 20114:20 pmRNSTotal Voting Rights
4th Apr 20117:00 amRNSEnterprise Securities Market Notice
31st Mar 20114:56 pmRNSTotal Voting Rights
30th Mar 20117:00 amRNSDirector Shareholding Notification
16th Mar 20117:00 amRNSEnterprise Securities Market Notice
14th Mar 20117:00 amRNSTrading Update
11th Mar 201110:00 amRNSIssue of Equity
11th Mar 20117:00 amRNSDirectorate Change
2nd Mar 20117:00 amRNSFirst Derivatives receives grant from Invest NI
24th Dec 201011:39 amRNSAdditional Listing
29th Nov 20104:32 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.